No photo of Farhad Vesuna

View Scopus Profile

Farhad Vesuna

Instructor

20022019

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Farhad Vesuna is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 6 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Targeting DDX3 in Medulloblastoma Using the Small Molecule Inhibitor RK-33

Tantravedi, S., Vesuna, F., Winnard, P. T., Martin, A., Lim, M., Eberhart, C. G., Berlinicke, C., Raabe, E., van Diest, P. J. & Raman, V., Jan 2019, In : Translational Oncology. 12, 1, p. 96-105 10 p.

Research output: Contribution to journal › Article

    • Targeting RNA helicase DDX3 in stem cell maintenance and teratoma formation

    Kerr, C. L., Bol, G. M., Vesuna, F. & Raman, V., Jan 1 2019, In : Genes and Cancer. 10, 1-2, p. 11-20 10 p.

    Research output: Contribution to journal › Article

    • Global Effects of DDX3 Inhibition on Cell Cycle Regulation Identified by a Combined Phosphoproteomics and Single Cell Tracking Approach

    Heerma van Voss, M. R., Kammers, K., Vesuna, F., Brilliant, J., Bergman, Y., Tantravedi, S., Wu, X., Cole, R. N., Holland, A., van Diest, P. J. & Raman, V., Jun 1 2018, In : Translational Oncology. 11, 3, p. 755-763 9 p.

    Research output: Contribution to journal › Article

    • Targeting mitochondrial translation by inhibiting DDX3: A novel radiosensitization strategy for cancer treatment

    Heerma Van Voss, M. R., Vesuna, F., Bol, G. M., Afzal, J., Tantravedi, S., Bergman, Y., Kammers, K., Lehar, M., Malek, R., Ballew, M., Ter Hoeve, N., Abou, D., Thorek, D., Berlinicke, C. A., Yazdankhah, M., Sinha, D., Le Thi, Q. H., Abrahams, R., Tran, P. T., Van Diest, P. J. & 1 others, Raman, V., Jan 4 2018, In : Oncogene. 37, 1, p. 63-74 12 p.

    Research output: Contribution to journal › Article

    • Combination treatment using DDX3 and PARP inhibitors induces synthetic lethality in BRCA1-proficient breast cancer

    Heerma van Voss, M. R., Brilliant, J. D., Vesuna, F., Bol, G. M., van der Wall, E., van Diest, P. J. & Raman, V., Mar 1 2017, In : Medical Oncology. 34, 3, 33.

    Research output: Contribution to journal › Article